| $385M | ||
| $350M | ||
| $215M | ||
| $88M | ||
| $82M | ||
| $62M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers the Symphony platform, a technology platform comprising the Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and the Symphony Cartridge, which includes reagents and components. It also provides the ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. Further, it is developing additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Over the last 12 months, insiders at Bluejay Diagnostics, Inc. have bought $0 and sold $0 worth of Bluejay Diagnostics, Inc. stock.
On average, over the past 5 years, insiders at Bluejay Diagnostics, Inc. have bought $92,359 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 500 shares for transaction amount of $1,635 was made by Dey Indranil (President and CEO) on 2023‑12‑13.
| 2023-12-13 | Dey Indranil | President and CEO | 500 0.044% | $3.27 | $1,635 | -85.64% | ||
| 2023-12-13 | Dey Svetlana | director | 500 0.0413% | $3.07 | $1,535 | -85.64% | ||
| 2023-03-28 | Dey Indranil | President and CEO | 2,000 0.0105% | $0.44 | $880 | -49.65% | ||
| 2023-03-27 | Dey Indranil | President and CEO | 8,000 0.0393% | $0.44 | $3,520 | -53.01% | ||
| 2023-03-24 | Dey Svetlana | director | 10,000 0.0502% | $0.44 | $4,400 | -51.67% | ||
| 2022-08-26 | Fisher Kenneth R | Chief Financial Officer | 20,000 0.0992% | $1.03 | $20,600 | -57.23% | ||
| 2022-04-25 | Fisher Kenneth R | Chief Financial Officer | 20,000 0.0943% | $0.99 | $19,800 | -21.74% | ||
| 2022-03-17 | Wurth Douglas Clark | 40,000 0.1983% | $1.18 | $47,120 | -24.35% | |||
| 2022-03-17 | Kinder Gordon Winston | Chief Financial Officer | 2,500 0.0122% | $1.16 | $2,898 | -24.35% | ||
| 2022-03-17 | Dey Svetlana | 10,000 0.0498% | $1.18 | $11,830 | -24.35% | |||
| 2022-03-16 | Wurth Douglas Clark | 60,000 0.2823% | $1.09 | $65,400 | -20.91% | |||
| 2022-03-14 | Kinder Gordon Winston | Chief Financial Officer | 5,000 0.0274% | $1.02 | $5,100 | +1.69% |
| Increased Positions | 5 | +125% | 11,256 | +28.48% |
| Decreased Positions | 2 | -50% | 31,543 | -79.82% |
| New Positions | 3 | New | 10,710 | New |
| Sold Out Positions | <1 | Sold Out | 14,942 | Sold Out |
| Total Postitions | 7 | +75% | 19,232 | -51.33% |
| Drw Securities, Llc | $39.00 | 2.99% | 59,767 | +59,767 | New | 2025-09-30 |
| Sabby Management, Llc | $19.00 | 1.48% | 29,628 | -66,405 | -69.15% | 2025-09-30 |
| Tower Research Capital Llc (Trc) | $3.00 | 0.22% | 4,448 | +2,176 | +95.78% | 2025-09-30 |
| Bank Of America Corp /De/ | $0 | <0.01% | 12 | +7 | +140% | 2025-09-30 |
| Ubs Group Ag | $0 | 0% | 0 | -444 | Sold Out | 2025-09-30 |
| Citigroup Inc | $0 | 0% | 0 | -241 | Sold Out | 2025-09-30 |